Impact of graft-versus-host disease on the clinical outcome of allogeneic hematopoietic stem cell transplantation for non-malignant diseases

[1]  T. Morio,et al.  Impact of low-dose irradiation and in vivo T-cell depletion on hematopoietic stem cell transplantation for non-malignant diseases using fludarabine-based reduced-intensity conditioning , 2018, Bone Marrow Transplantation.

[2]  E. Lanino,et al.  Evaluation of Chimerism Dynamics after Allogeneic Hematopoietic Stem Cell Transplantation in Children with Nonmalignant Diseases. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  Motohiro Kato,et al.  Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemia , 2018, Bone Marrow Transplantation.

[4]  M. Zahurak,et al.  Alternative Donor Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Refractory Severe Aplastic Anemia. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[5]  J. Kanda,et al.  Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation , 2017, Leukemia.

[6]  T. Morio,et al.  Comparison of second transplantation and donor lymphocyte infusion for donor mixed chimerism after allogeneic stem cell transplantation for nonmalignant diseases , 2016, Pediatric blood & cancer.

[7]  B. Burkhardt,et al.  The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis. , 2016, Blood.

[8]  K. Myers,et al.  Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab Regimen. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  A. Schulz,et al.  Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  R. Porcher,et al.  Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience. , 2013, Blood.

[11]  A. Schulz,et al.  Allo-SCT using BU, CY and melphalan for children with AML in second CR , 2013, Bone Marrow Transplantation.

[12]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[13]  Richard J. Jones,et al.  HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease. , 2012, Blood.

[14]  S. Adachi,et al.  Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: a nationwide survey in Japan. , 2012, Molecular genetics and metabolism.

[15]  Tao Wang,et al.  Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders. , 2012, Blood.

[16]  R. Porcher,et al.  Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning , 2012, Haematologica.

[17]  P. Veys,et al.  Reduced-intensity conditioning for allogeneic stem cell transplant in primary immune deficiencies , 2012, Expert review of clinical immunology.

[18]  H. Im,et al.  Clinical implications of chimerism after allogeneic hematopoietic stem cell transplantation in children with non-malignant diseases , 2011, The Korean journal of hematology.

[19]  S. Davies,et al.  Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation. , 2010, Blood.

[20]  B. Alter,et al.  Pathophysiology and management of inherited bone marrow failure syndromes. , 2010, Blood reviews.

[21]  B. Sandmaier,et al.  Defining the intensity of conditioning regimens: working definitions. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[22]  B. Bigger,et al.  Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy. , 2009, The Journal of pediatrics.

[23]  K. Myers,et al.  Hematopoietic stem cell transplantation for bone marrow failure syndromes in children. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[24]  W. Grossman,et al.  Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis , 2008, Bone Marrow Transplantation.

[25]  K. Kawa,et al.  Unification of Hematopoietic Stem Cell Transplantation Registries in Japan and Establishment of the TRUMP System , 2007, International journal of hematology.

[26]  T. Klingebiel,et al.  Outcome of allogeneic stem cell transplantation in children with non-malignant diseases. , 2006, Haematologica.

[27]  F. Locatelli,et al.  Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis , 2005, British journal of haematology.

[28]  W. Tse,et al.  Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children , 2004, The Lancet.

[29]  K. Kawa,et al.  Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate , 2004, Leukemia.

[30]  B. Alter.  Cancer in Fanconi anemia, 1927–2001 , 2003, Cancer.

[31]  N. Kröger,et al.  Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single‐centre experience of 12 patients , 1999, British journal of haematology.

[32]  H. Esperou,et al.  Transplantation for Fanconi's anaemia: long‐term follow‐up of fifty patients transplanted from a sibling donor after low‐dose cyclophosphamide and thoraco‐abdominal irradiation for conditioning , 1998, British journal of haematology.

[33]  E D Thomas,et al.  1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.

[34]  A. Rimm,et al.  Graft-versus-leukemia reactions after bone marrow transplantation. , 1990, Blood.

[35]  K. Sullivan,et al.  Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. , 1980, The American journal of medicine.